APA (7th ed.) Citation

Kries, A. v., Garcés Lázaro, I., Balzasch, B. M., Sticht, C., Shaltiel, I. A., Boonekamp, K. E., . . . Cerwenka, A. (2025). Colorectal cancer organoids drive hypoxia, TGF-β, and patient-specific diversification of NK cell activation programs. Journal for ImmunoTherapy of Cancer, 13(12), . https://doi.org/10.1136/jitc-2025-012988

Chicago Style (17th ed.) Citation

Kries, Andreas von, et al. "Colorectal Cancer Organoids Drive Hypoxia, TGF-β, and Patient-specific Diversification of NK Cell Activation Programs." Journal for ImmunoTherapy of Cancer 13, no. 12 (2025). https://doi.org/10.1136/jitc-2025-012988.

MLA (9th ed.) Citation

Kries, Andreas von, et al. "Colorectal Cancer Organoids Drive Hypoxia, TGF-β, and Patient-specific Diversification of NK Cell Activation Programs." Journal for ImmunoTherapy of Cancer, vol. 13, no. 12, 2025, https://doi.org/10.1136/jitc-2025-012988.